Pharma-Bio Serv Inc. (OTCMKTS:PBSV – Get Free Report) shares passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.60 and traded as high as $0.62. Pharma-Bio Serv shares last traded at $0.62, with a volume of 3,973 shares.
Pharma-Bio Serv Stock Down 7.5%
The business has a fifty day simple moving average of $0.60 and a 200-day simple moving average of $0.53. The firm has a market cap of $14.22 million, a P/E ratio of -62.00 and a beta of 0.76.
Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) last posted its quarterly earnings data on Monday, September 15th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.04). The firm had revenue of $1.96 million during the quarter, compared to the consensus estimate of $3.00 million. Pharma-Bio Serv had a negative return on equity of 0.68% and a negative net margin of 0.91%. On average, sell-side analysts anticipate that Pharma-Bio Serv Inc. will post 0.11 EPS for the current fiscal year.
About Pharma-Bio Serv
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.
Recommended Stories
- Five stocks we like better than Pharma-Bio Serv
- Using the MarketBeat Dividend Yield Calculator
- General Dynamics Hits New Highs: Why It Might Keep Climbing
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Nike’s Turnaround: If the Shoe Fits, Buy It!
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- NVIDIA Breaks Out to New Highs: What Comes Next?
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.